| Literature DB >> 28700942 |
Valeria Amodeo1, Deli A1, Joanne Betts1, Stefano Bartesaghi1, Ying Zhang2, Angela Richard-Londt2, Matthew Ellis2, Rozita Roshani1, Mikaella Vouri1, Sara Galavotti1, Sarah Oberndorfer1, Ana Paula Leite1, Alan Mackay3, Aikaterini Lampada1, Eva Wessel Stratford4, Ningning Li2, David Dinsdale5, David Grimwade6, Chris Jones3, Pierluigi Nicotera7, David Michod8, Sebastian Brandner2, Paolo Salomoni9.
Abstract
Cell migration through the brain parenchyma underpins neurogenesis and glioblastoma (GBM) development. Since GBM cells and neuroblasts use the same migratory routes, mechanisms underlying migration during neurogenesis and brain cancer pathogenesis may be similar. Here, we identify a common pathway controlling cell migration in normal and neoplastic cells in the CNS. The nuclear scaffold protein promyelocytic leukemia (PML), a regulator of forebrain development, promotes neural progenitor/stem cell (NPC) and neuroblast migration in the adult mouse brain. The PML pro-migratory role is active also in transformed mouse NPCs and in human primary GBM cells. In both normal and neoplastic settings, PML controls cell migration via Polycomb repressive complex 2 (PRC2)-mediated repression of Slits, key regulators of axon guidance. Finally, a PML/SLIT1 axis regulates sensitivity to the PML-targeting drug arsenic trioxide in primary GBM cells. Taken together, these findings uncover a drug-targetable molecular axis controlling cell migration in both normal and neoplastic cells.Entities:
Keywords: PML; Polycomb; Slit; cell migration; glioblastoma; neurogenesis; nuclear lamina
Mesh:
Substances:
Year: 2017 PMID: 28700942 DOI: 10.1016/j.celrep.2017.06.047
Source DB: PubMed Journal: Cell Rep Impact factor: 9.423